Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results

Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results

Bibliographic Details
Main Authors:	Cigdem Yuce Kahraman, Gulden Sincan, Abdulgani Tatar
Format:	Article
Language:	English
Published:	AVES 2022-06-01
Series:	Eurasian Journal of Medicine
Online Access:	https://www.eajm.org/en/next-generation-sequencing-panel-test-in-myeloid-neoplasms-and-evaluation-with-the-clinical-results-133398

Similar Items

Evaluation of the Relationship between Janus Kinase 2 Mutational Burden and Clinical Findings in Adult Myeloproliferative Neoplasm Patients
by: Cigdem Yuce Kahraman, et al.
Published: (2022-01-01)

P190: Validation of myeloid neoplasm next generation sequencing panel for acute myeloid leukemia and myeloid malignancies in Singapore
by: Than Hein, et al.
Published: (2023-01-01)

Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neoplasms.
by: Borahm Kim, et al.
Published: (2019-01-01)

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms
by: Diego Carbonell, et al.
Published: (2019-09-01)

Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition
by: Cristina Andrés‐Zayas, et al.
Published: (2021-09-01)

Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.
by: Sun Hee Rosenthal, et al.
Published: (2021-01-01)

Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms.
by: Daichi Sadato, et al.
Published: (2021-01-01)

Is There an Association Between Nasal Polyposis and ADAMTS Genes Expressions?
by: Cigdem Yuce Kahraman, et al.
Published: (2021-02-01)

PB2031: NEXT GENERATION SEQUENCING IN MYELOID NEOPLASMS: DEVELOPING WORLD DATA FROM SINGLE CENTRE
by: Nida Anwar, et al.
Published: (2023-08-01)

Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms
by: Lamia Madaci, et al.
Published: (2023-06-01)

Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations
by: María Chicano, et al.
Published: (2021-06-01)

PB1777: DEVELOPMENT OF NEXT GENERATION SEQUENCING PANELS FOR SCREENING FUSION GENES IN LEUKEMIA
by: S. Çiğdem, et al.
Published: (2022-06-01)

Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests
by: Jihun Kim, et al.
Published: (2017-05-01)

A Novel Mutation of <i>ATP7B</i> Gene in a Case of Wilson Disease
by: Cigdem Yuce Kahraman, et al.
Published: (2021-01-01)

Clinical Utility of Optical Genome Mapping and 523-Gene Next Generation Sequencing Panel for Comprehensive Evaluation of Myeloid Cancers
by: Nikhil Shri Sahajpal, et al.
Published: (2023-06-01)

The Progress of Next Generation Sequencing in the Assessment of Myeloid Malignancies
by: Fulya Öz Puyan, et al.
Published: (2019-03-01)

Utility of metagenomic Next-Generation Sequencing for simultaneously detecting pathogens and neoplasms
by: Feng Qin, et al.
Published: (2024-01-01)

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms
by: Paula Aguirre-Ruiz, et al.
Published: (2020-11-01)

Comparative Analyses of Targeted Myeloid Cancer Next-Generation Sequencing Panel in Fresh Blood, Bone Marrow and FFPE Material
by: Andrea Daniela Hobeck, et al.
Published: (2024-03-01)

Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China
by: Junnan Li, et al.
Published: (2023-04-01)

BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing
by: Aleksandra Mroczkowska-Bękarciak, et al.
Published: (2023-09-01)

Dissecting Genomic Aberrations in Myeloproliferative Neoplasms by Multiplex-PCR and Next Generation Sequencing.
by: Martin M J Kirschner, et al.
Published: (2015-01-01)

A Targeted Next-Generation Sequencing Panel to Genotype Gliomas
by: Maria Guarnaccia, et al.
Published: (2022-06-01)

Incidental findings from cancer next generation sequencing panels
by: Nika Maani, et al.
Published: (2021-07-01)

Clinical Utility of Next-generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single-Center Experience
by: Waleed Alduaij, et al.
Published: (2018-06-01)

Discovering myeloid cell heterogeneity in the lung by means of next generation sequencing
by: Jing-jing Ji, et al.
Published: (2019-10-01)

Clinical Applications of Next Generation Sequencing in Cancer: From panels, to exomes, to genomes
by: Tony eShen, et al.
Published: (2015-06-01)

Screening a Targeted Panel of Genes by Next-Generation Sequencing Improves Risk Stratification in Real World Patients with Acute Myeloid Leukemia
by: Sónia Matos, et al.
Published: (2022-06-01)

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
by: Russell J. Diefenbach, et al.
Published: (2020-08-01)

Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
by: Alicia Scocchia, et al.
Published: (2021-10-01)

Development of next generation sequencing panel for UMOD and association with kidney disease.
by: Caitlin Bailie, et al.
Published: (2017-01-01)

Inter-assay variability of next-generation sequencing-based gene panels
by: Pham Nguyen Quy, et al.
Published: (2022-04-01)

Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
by: Holly LaDuca, et al.
Published: (2017-01-01)

THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES
by: Emine Atli, et al.
Published: (2021-01-01)

Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era
by: Jong-Mi Lee, et al.
Published: (2021-03-01)

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
by: Nathalie E. Synhaeve, et al.
Published: (2018-11-01)

Correction to: Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
by: Alicia Scocchia, et al.
Published: (2022-02-01)

What’s Next after Hypomethylating Agents Failure in Myeloid Neoplasms? A Rational Approach
by: Hussein Awada, et al.
Published: (2023-04-01)

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies
by: Pierre Sujobert, et al.
Published: (2019-02-01)

Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers
by: Arnaud Bayle, et al.
Published: (2021-11-01)